Activity of Crizotinib in MET Amplified NSCLC: Preliminary Results of the AcSe Trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreActivity of Crizotinib in MET Amplified NSCLC: Preliminary Results of the AcSe Trial
Type de publicationJournal Article
Year of Publication2015
AuteursMoro-Sibilot D, Le Deley M-C, Zalcman G, Bota S, Sabatier R, Souquet PJean, Favier L, Poudenx M, Bombaron P, Audigier-Valette C, Bernard P, Foucher P, Girard N, Merlio J-P, Arnould L, Ferretti G, Mortier T, Lonchamp E, Vassal G, Oukhatar CMahier-Ait
JournalJOURNAL OF THORACIC ONCOLOGY
Volume10
PaginationS178
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN1556-0864
Mots-clésbiomarkers, Crizotinib, MET amplification, NSCLC